The emergence of Retatrutide in the UK is sparking significant buzz within the weight management community. This innovative dual medication – targeting both GLP-1 and GIP – suggests a remarkably new solution to combating obesity . Currently , options have been restricted for many, and Retatrutide embodies a promising prospect for patients seeki